Guggenheim Capital’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,750
Closed -$63.6K 1584
2025
Q2
$63.6K Buy
10,750
+371
+4% +$2.13K ﹤0.01% 1577
2025
Q1
$66.3K Buy
+10,379
New +$100K ﹤0.01% 1623
2023
Q1
Sell
-36,468
Closed -$430K 1916
2022
Q4
$430K Sell
36,468
-6,229
-15% -$71.2K ﹤0.01% 1550
2022
Q3
$393K Buy
42,697
+4,381
+11% +$53.1K ﹤0.01% 1572
2022
Q2
$379K Buy
38,316
+20,778
+118% +$419K ﹤0.01% 1692
2022
Q1
$605K Buy
17,538
+8,565
+95% +$278K ﹤0.01% 1606
2021
Q4
$447K Sell
8,973
-23,777
-73% -$1.25M ﹤0.01% 1733
2021
Q3
$1.51M Sell
32,750
-10,310
-24% -$409K 0.01% 1197
2021
Q2
$1.29M Buy
+43,060
New +$879K 0.01% 1341

Other funds holding ASPN

Guggenheim Capital's ASPN Position: Q3 2025 in Review

Guggenheim Capital sold out of Aspen Aerogels (ASPN) in Q3 2025, closing a stake of 10,750 shares — an estimated $63.6K sold.

Guggenheim Capital first reported a position in ASPN in Q2 2021 and held it in 9 quarters. The position peaked at $1.51M in Q3 2021. 204 funds tracked by Wall St. Rank hold ASPN as of Q3 2025.

  • Guggenheim Capital reported no remaining Aspen Aerogels position as of Q3 2025 after selling out during the quarter.
  • Guggenheim Capital sold 10,750 Aspen Aerogels shares in Q3 2025, an estimated $63.6K.
  • Guggenheim Capital first reported a position in Aspen Aerogels in Q2 2021 and held it in 9 quarters.
  • Guggenheim Capital's Aspen Aerogels position peaked at $1.51M in Q3 2021.
  • 204 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2025.

Based on Guggenheim Capital's 13F filing for Q3 2025, filed 13 Nov 2025.